In cancer, many pathways may entail over-activation of the PI3K/AKT signaling, and it is becoming increasingly evident that NOX-derived ROS production may contribute to cancer tumorigenesis at least in part via stimulating the PI3K/AKT pathway. The gene discussed is AKT1; the disease is cancer.